A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin IR Tablets (2 x 850 mg) in Healthy Volunteers

Name: A Study to Assess the Bioequivalence of 2 Fixed Dose Combination (FDC) Tablets of Canagliflozin and Metformin Immediate Release (IR) (150 mg/850 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin IR Tablets (2 x 850 mg) in Healthy Volunteers
License: Public Domain

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

healthy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 383546
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.